Please assess the completion status of the following clinical trial:

Trial Title: A Prospective Study of HBV Immunity and HBV Vaccination in Patients With NAFLD in Canada

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Subjects 18-60 years of age, who provide signed informed consent~* Diagnosis of NAFLD/NASH according to expert assessment (by imaging, TE, abnormal lab tests and/or liver biopsy)~* No evidence of prior infection or immunity to hepatitis B (negative HBsAg, anti-HBs, anti-HBc).~Exclusion Criteria:~* Subjects \< 18 years of age,~* Subjects who refused vaccination~* Have documented immunity / prior exposure to hepatitis B (i.e., positive for ant-HBs, anti-HBc, HBsAg)~* Pregnancy~* HIV-positive~* Decompensated cirrhosis (i.e., Child-Pugh Class B or C) due to impact on immune response.~* Subjects \>60 y will be excluded, due to effect of age and reduced response to HBV vaccination.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 60 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).